Inflammatory bowel disease (IBD), an umbrella term for a number of gut disorders -- including ulcerative colitis and Crohn's disease -- remains a clinical challenge. Now, researchers have identified a protein that drives intestinal inflammation. This finding highlights new opportunities for creating targeted therapeutics.